Table 2.
Univariate and multivariate Cox regression models of the 15-gene signature in predicting survival of advanced CRC.
HR (95% CI) |
HR (95% CI) |
|||
---|---|---|---|---|
Factors | Univariate Cox analysis | P | Multivariate Cox analysis | P |
TCGA training set | ||||
Risk score (high vs. low) | 8.00 (4.35–14.73) | <0.001 | 8.19 (4.32–15.54) | <0.001 |
Age (≥60 vs. <60 years) | 1.79 (1.08–2.98) | 0.025 | 1.98 (1.14–3.43) | 0.015 |
Gender (male vs. female) | 0.97 (0.62–1.50) | 0.879 | ||
Distal metastasis (positive vs. negative) | 2.53 (1.60–4.00) | <0.001 | 2.61 (1.65–4.15) | <0.001 |
Validation set | ||||
Risk score (high vs. low) | 3.85 (2.58–5.74) | <0.001 | 3.21 (2.14–4.84) | <0.001 |
Age (≥60 vs. <60 years) | 1.37 (0.89–2.11) | 0.152 | ||
Gender (male vs. female) | 1.40 (0.95–2.05) | 0.088 | ||
Distal metastasis (positive vs. negative) | 4.15 (2.74–6.27) | <0.001 | 3.55 (2.34–5.38) | <0.001 |
TCGA: The Cancer Genome Atlas; CRC: colorectal cancer; HR: hazard ratio; CI: confidence interval.